WHC is still in active development. Read this to understand our approach.
depiction of RAFUPYYDHPFASC-UHFFFAOYSA-N.svg
tripsit

1cp-lsd

Verificar en tripsit

psychonaut

1cP-LSD

Verificar en psychonaut

isomerdesign

1cP-LSD

Verificar en isomerdesign

druglab

1cP-LSD

Verificar en druglab

wiki

1cP-LSD

Verificar en wiki

Data

InChI: InChI=1S/C24H29N3O2/c1-4-26(5-2)23(28)17-11-19-18-7-6-8-20-22(18)16(12-21(19)25(3)13-17)14-27(20)24(29)15-9-10-15/h6-8,11,14-15,17,21H,4-5,9-10,12-13H2,1-3H3

Sinónimos: 1cP-LSD,1cplsd,1CP-LSD,7UU7S6TN3J,N1-(CYCLOPROPYLMETHANOYL)-LYSERGIC ACID DIETHYLAMIDE,1-CYCLOPROPIONYL LSD,curie,(6AR,9R)-4-(CYCLOPROPANECARBONYL)-N,N-DIETHYL-7-METHYL-4,6,6A,7,8,9-HEXAHYDROINDOLO(4,3-FG)QUINOLINE-9-CARBOXAMIDE,1cp,1-CPA-LSD

Market name: 1cp-lsd

Estimated data

Solubilidad: -3.912 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 50.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.